期刊文献+

脓毒症与炎性细胞 被引量:10

Sepsis and Inflammatory Cells
下载PDF
导出
摘要 脓毒症是指各种致病微生物或其毒素存在于血液或组织中,是世界范围内重症病患的首位死亡原因,是ICU所面临的医学难题之一。脓毒症是机体对感染的一种全身性炎性反应,发病机制相当复杂,既可由感染因素引起,亦可由非感染因素所引起,往往不是由单一的因素所造成,可能同时存在促炎性反应及抗炎性反应,免疫麻痹、凝血机制的异常亦可能参与了脓毒症的发生发展。单核细胞、多形核白细胞和多种免疫细胞受炎性介质的作用,在脓毒症的炎性反应的过程中发挥了重要的作用。 Sepsis is caused by various kinds pathogenic microorganisms or their toxin in the blood or in the tissue, which has been the first reason resulting in the critical patient death and it is one of the medical tough problems. The pathogeaesy of sepsis is really complex associated with infection or not, and both proinflammatory and anti-inflammatory tray be involved in simultaneously. Furthermore, immunological paralysis and dysfunction of clotting mechanism paticipate in the development of sepsis at the same time. During the inflammatory of sepsis, inflammation mediators affect monecyte, polymorphonuclear leukocyte and immunocell, all of which contribute to the development of sepsis.
出处 《医学综述》 2008年第2期277-279,共3页 Medical Recapitulate
关键词 脓毒症 炎性细胞 多形核白细胞 淋巴细胞 内皮细胞 单核细胞 Sepsis Inflammatory cells Polymorphonuclear leukocyte Lyphocyte Endotheliocyte Monocyte
  • 相关文献

参考文献20

  • 1Angus DC,Linde-Zwinble WT,Lidicker J,et al.Epidemiology of severe sepsis in the United States:analysis of incidence,outcome,and associated costs of care[J].Crit Care Med,2001,29(5):1303-1310.
  • 2No authors listed.American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference:definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis[J].Crit Care Med,1992,20(6):864-874.
  • 3Bone RC.Sir Isaac Newton,sepsis,SIRS,and CARS[J].Crit Care Med,1996,24(7):1125-1128.
  • 4Warren HS.Strategies for the treatment of sepsis[J].N Engl J Med,1997,336(13):952-953.
  • 5Kotani M,Kotani T,Ishizaka A,et al.Neutrophil depletion attenuates interleukin-8 production in mild-overstretch wentilated normal rabbit lung[J].Crit Care Med,2004,32(2):514-519.
  • 6Cinsburg I.The role of bacteriolysis in the pathophysiology of inflammation,infection and post-infectious sequelae[J].APMS,2002,110(11):753-770.
  • 7Power C,Wang JH,Soakhai S,et al.Proinflammatory effects of bacterial lipoprotein on human neutrophil activation status,function and cytotoxic potential in vitro[J].Shock,2002,15(6):461-466.
  • 8Welsh CH,Lien DC,Worthen CS,et al.Endotoxin-pretreated neutrophils increase pulmonary vascular pemeability in dogs[J].J Appl Paysiol,1989,66(1):112-119.
  • 9陈莉萍,颜亮,杨皓庄,张穗梅.腹腔感染脓毒症小鼠外周血淋巴细胞CD30的动态表达[J].中国病理生理杂志,2002,18(12):1468-1471. 被引量:1
  • 10Hotchkiss RS,Tinsley KW,Swanson PE,et al.Sepsis-induced apotosis causes progressive profound depletion of B and CD4^+ T lymphocytes in human[J].J Immunol,2001,166(11):6952-6963.

二级参考文献13

  • 1[1]Mack VE, McCarter MD, Naama HA, et al. Dominance of T-helper 2-type cytokines after severe injury[J]. Arch Surg, 1996, 131(12): 1303-1309.
  • 2[2]Ono S, Ueno C, Aosasa S, et al. Severe sepsis induces deficient interferon-gamma and interleukin-12 production, but interleukin-12 therapy improves survival in peritonitis[J]. Am J Surg, 2001, 182(5): 491-497.
  • 3[3]Del Prete G, De Carli M, Almerigogna F, et al. Preferential expression of CD30 by human CD4+T cells producing Th2-type cytokines[J]. FASEB J, 1995, 9(1): 81-86.
  • 4[4]Bone RC. Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS)[J]. Ann Intern Med, 1996, 125(8): 680-687.
  • 5[5]Bone RC. Sir isaac newton, sepsis, SIRS, and CARS[J]. Crit Care Med, 1996, 24(7): 1125-1128.
  • 6[6]Infante-Duarte C, Kamradt T. Th1/Th2 balance in infection[J]. Springer Semin Immunopathol, 1999, 21(3):317-338.
  • 7[7]Fink MP, Heard SO. Labroatory models of sepsis and septic shock[J]. Srug Res, 1990, 49(2): 186-196.
  • 8[8]Stein H, Mason DY, Gerdes J, et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissure: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells[J]. Blood, 1985, 66(4): 848-858.
  • 9[9]Gruss HJ, Boiani N, Williams DE, et al. Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines[J]. Blood, 1994, 83(8): 2045-2056.
  • 10[10]Delprete G, De carli M, D'Elios MM, et al. CD30-mediated signaling promotes the development of human T helper type 2-lilke T cells[J]. J Exp Med, 1995, 182(6):1655-1661.

同被引文献63

引证文献10

二级引证文献91

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部